Comprehensive reagents for immunophenotyping rabbit cell-mediated immunity.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93020C00023
- Awardee
-
Abterra Biosciences, Inc. UEI TYHDLNB65NJ1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $540,608
Award facts
- Opportunity
-
- PHS202001 Solicitation number
- Contract value 100% obligated
- $540,608.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $540,608 |
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $540,608 firm fixed price definitive contract to Abterra Biosciences, Inc., doing business as Digital Proteomics, as part of the Small Business Innovation Research Program Phase I solicitation. Under the contract, Digital Proteomics will deliver comprehensive reagents for immunophenotyping rabbit cell-mediated immunity to support research related to allergies and infectious diseases. Place of performance is San Diego, California. The two-year contract was awarded on July 1, 2020 with a period of performance through December 31, 2022. The award is designated as a total small business set aside.
Quick answers
Who was awarded contract 75N93020C00023?
75N93020C00023 was awarded to Abterra Biosciences, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2020.
How much is contract 75N93020C00023 worth?
The government has obligated $540,608 on 75N93020C00023.
Was contract 75N93020C00023 competed?
The extent of competition for 75N93020C00023 was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award